| Name | Sector |
Revenue
$mlns |
M&A Activity | Last 5 Years | ||
|---|---|---|---|---|---|---|
| Total | Buy | Sell | ||||
|
Charles River Laboratories International
NYSE : CRL Wilmington, Massachusetts, United States website |
Life Science | 4,050 | 34 | 31 | 3 |
|
|
Azenta
NASDAQ : AZTA Burlington, Massachusetts, United States website |
Life Science | 656 | 29 | 24 | 5 |
|
|
Ginkgo Bioworks
NYSE : DNA Boston, Massachusetts, United States website |
Life Science | 227 | 15 | 14 | 1 |
|
|
Repligen
NASDAQ : RGEN Waltham, Massachusetts, United States website |
Life Science | 634 | 12 | 11 | 1 |
|
NASDAQ : BIIB Cambridge, Massachusetts, United States website |
Life Science | 9,676 | 11 | 10 | 1 |
|
|
Vertex Pharmaceuticals
NASDAQ : VRTX Boston, Massachusetts, United States website |
Life Science | 11,020 | 10 | 8 | 2 |
|
|
Agenus
NASDAQ : AGEN Lexington, Massachusetts, United States website |
Life Science | 103 | 4 | 3 | 1 |
|
|
Collegium Pharmaceutical
NASDAQ : COLL Stoughton, Massachusetts, United States website |
Life Science | 631 | 3 | 3 | - |
|
|
Ernexa Therapeutics
NYSE : ERNA Cambridge, Massachusetts, United States website |
Life Science | - | 3 | 3 | - |
|
|
Organogenesis
NASDAQ : ORGO Canton, Massachusetts, United States website |
Life Science | 482 | 3 | 3 | - |
|
|
CervoMed
NASDAQ : CRVO Boston, Massachusetts, United States website |
Life Science | - | 2 | 2 | - |
|
|
Eloxx Pharmaceuticals
Public Watertown, Massachusetts, United States website |
Life Science | 34 | 2 | 2 | - |
|
|
Spectrum Pharmaceuticals
Public Boston, Massachusetts, United States website |
Life Science | 26 | 3 | 2 | 1 |
|
|
XenoTherapeutics
NASDAQ : XOMA Boston, Massachusetts, United States website |
Life Science | 9 | 2 | 2 | - |
|
|
Apellis Pharmaceuticals
NASDAQ : APLS Waltham, Massachusetts, United States website |
Life Science | 781 | 1 | 1 | - |
|
|
Aldeyra Therapeutics
NASDAQ : ALDX Lexington, Massachusetts, United States website |
Life Science | - | 1 | 1 | - |
|
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr was built to make it easy to understand who owns which companies — and how they got there.
Whether you're researching private equity-backed businesses, recent acquisitions, or potential targets, Mergr provides structured access to thousands of companies, investors, and ownership histories.
The platform is powerful but easy to use — so you can quickly surface relevant companies and move from research to action.
Full access to Mergr's investor, acquirer, and transaction data starts here.
